tosufloxacin has been researched along with Infections, Pseudomonas in 2 studies
tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin was 1 to 3 twofold dilutions more active than A-61827 against these gram-negative bacteria." | 1.27 | A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. ( Bower, RR; Chu, DT; Fernandes, PB; Hanson, CW; Hardy, DJ; Ramer, NR; Stamm, JM; Swanson, RN, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubert, G | 1 |
| Pozzetto, B | 1 |
| Dorche, G | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Swanson, RN | 1 |
| Ramer, NR | 1 |
| Hanson, CW | 1 |
| Bower, RR | 1 |
| Stamm, JM | 1 |
| Hardy, DJ | 1 |
2 other studies available for tosufloxacin and Infections, Pseudomonas
| Article | Year |
|---|---|
Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Huma | 1992 |
A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacteroides Infecti | 1988 |